Autoimmune kidney diseases and their management

Autoimmune kidney diseases, such as lupus nephritis and anti-glomerular basement membrane (GBM) disease, occur when the immune system mistakenly attacks the kidneys, leading to inflammation and damage. Management of autoimmune kidney diseases involves suppressing the immune system to reduce inflammation and prevent further kidney damage. This can be achieved through the use of immunosuppressive medications such as corticosteroids, cyclophosphamide, and mycophenolate mofetil. In severe cases, plasmapheresis or intravenous immunoglobulin (IVIG) may also be used to remove harmful antibodies from the blood. Regular monitoring of kidney function and urine protein levels is essential in managing autoimmune kidney diseases and preventing disease progression.

    Related Conference of Autoimmune kidney diseases and their management

    May 26-27, 2025

    29th European Nephrology Conference

    Rome, Italy
    June 23-24, 2025

    14th International Conference on Nephrology & Therapeutics

    Aix-en-Provence, France
    August 28-29, 2025

    10th World Kidney Congress

    London, UK
    March 26-27, 2026

    22nd World Nephrology Conference

    Amsterdam, Netherlands

    Autoimmune kidney diseases and their management Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in